<DOC>
	<DOC>NCT00730145</DOC>
	<brief_summary>1. Quantify how much PD-0332334 is removed from the blood with hemodialysis 2. Investigate the pharmacokinetics of a single dose of PD-0332334 in subjects receiving regular hemodialysis treatments. 3. Investigate the safety and tolerability of a single dose of PD-0332334 in subjects receiving hemodialysis.</brief_summary>
	<brief_title>A Single Dose Study Investigating The Elimination Of PD-0332334 In Patients Receiving Regular Hemodialysis</brief_title>
	<detailed_description>Assess the elimination of PD-0332334 from the blood with hemodialysis</detailed_description>
	<criteria>Patients receiving regular hemodialysis Male or female patients 18 to 65 years Severe heart failure Renal transplant or renal allograft Illicit drug use (with the exception of prescribed sedatives)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2010</verification_date>
	<keyword>pharmacokinetics, PD-0332334, hemodialysis, renal dialysis</keyword>
</DOC>